Restrictive practices in trade in pharmaceutical products

(2020 data) The stomach-acid drug Nexium, is manufactured in Sweden. One 40mg pill costs $7.78 in the USA compared to $3.37 in Canada. The price drops even more to $2.21 in the U.K., Australia and New Zealand. In India and Turkey, the same pill costs less than 37 cents. The antipsychotic drug Abilify is manufactured in Japan. The cost in the USA is $34.51 per pill. The same pill costs $4.65 in Canada - 87-percent less than in the U.S.

Fear of political and legal reprisals from the USA pharmaceutical industry has prevented the WHO from giving international approval to a new abortion pill, so inhibiting its world-wide marketing for family planning purposes.

1. Underdevelopment of the pharmaceutical industry
2. Restrictive practices in trade in manufactured goods
3. Irresponsible pharmaceutical practices

1. Refusal to market new drugs
2. Non-responsiveness of transnational corporations to pharmaceutical needs
3. Excessive restrictions to legalizing medications
4. Embargo on medicines

1. Secrecy about pharmaceutical products
2. Restriction of abortion
3. Insufficient medical supplies
4. Distortion of international trade by discriminatory formulation of health and sanitary regulations for agricultural and pharmaceutical products
5. Criminalization of drug use
6. Confusion among drugs with similar names

1. Unethical pharmaceutical practices
2. Unauthorized pharmaceutical manufacture and distribution
3. Medication side effects
4. Economic retaliation

1. Marketing of banned pharmaceutical drugs
2. Excessive proliferation of medical drugs

1. Ineffective self-regulation in the pharmaceutical and medical devices industries

1. Restricting sale of prescription drugs via the internet

1. Restriction
2. Nonrestrictive